Date Medication Mode of Dosage Indications Contraindicatio Side Effects/ Nursing

Ordered Action n Adverse Responsibilities

Effects
October Generic Name: Increases PO 15 Treatment of Contraindicated Baseline
05, Lactulose water content ml @ chronic in patients on GI: Belching, Assessment:
2021, and softens bedtime constipation in low-galactose cramps,
7:00AM Brand Name: the stool. x5 adults and diets. distention,  Assess patient
Cephulac Lowers the pH days. geriatric flatulence, for abdominal
of the colon, patients. Use cautiously in diarrhea distention,
Classification: which inhibits Adjunct in the diabetes mellitus; presence of
Therapeutic: the diffusion of management of excessive or Endo: bowel sound,
Laxatives ammonia from portal-systemic prolonged use hyperglycemia and normal
the colon into (hepatic) (may lead to (diabetic pattern of
Pharmacologic: the blood, encephalopath dependence); patient) bowel function.
Osmotics thereby y (PSE) pregnancy,  Assess color,
reducing lactation, or consistency,
Pregnancy blood children (safety and amount of
Category B ammonia not established) stool produced.
levels.  PSI: Assess
mental status
REFERENCE: (orientation,
J.H Deglin level of
and A.H consciousness)
Vallerand before and
(2007) Davis’s periodically
Drug Guide throughout
for Nurses course of
(10th Edition) therapy.
Philadelphia,
F.A Davis Lab test
Company. Consideration:

 Decreases
blood ammonia
concentrations
by 25-30%.
 May cause
increased
blood glucose
levels to
diabetic
patients.
 Monitor serum
electrolytes
periodically
when used
chronically.
May cause
diarrhea with
resulting
hypokalemia
and
hypernatremia.

Patient/ Family
Teaching:

 Encourage
patients to use
other forms of
bowel
 regulation,
such as
increasing bulk
in the diet,
increasing fluid
intake, and
increasing
mobility.
Normal habits
are
individualized
and may vary
from 3
times/day to 3
times/week.
 Caution patient
that this
medication may
cause belching,
flatulence, or
abdominal
cramping.
Health care
professional
should be
notified if this
becomes
bothersome or
if diarrhea
occurs.

Evaluation/
Desired outcome:
  Passage of a
soft, formed
bowel
movement
usually within
2-48hr.
 Clearing of
confusion,
apathy, and
irritation and
improved
mental status in
PSI.
Improvement
may occur
within 2 hr.
after enema
and 24-48 hr.
after oral
administration.

Evelyn R. Lampios, SN
Name of Student